BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2933357)

  • 1. The clinical significance of alpha 1-antitrypsin-elastase (alpha 1AT-ELP) and alpha 2-antiplasmin-plasmin (alpha 2AP-PL) complexes for the differentiation of coagulation protein turnover: indications for plasma protein substitution in patients with septicaemia.
    Seitz R; Egbring R; Radtke KP; Wolf M; Fuchs G; Fischer J; Lerch L; Karges HE
    Int J Tissue React; 1985; 7(4):321-8. PubMed ID: 2933357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.
    Brower MS; Harpel PC
    Blood; 1983 May; 61(5):842-9. PubMed ID: 6219725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination.
    Egbring R; Seitz R
    Z Gastroenterol; 1990 Feb; 28(2):104-9. PubMed ID: 2138832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
    Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
    J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections.
    Seitz R; Wolf M; Egbring R; Radtke KP; Liesenfeld A; Pittner P; Havemann K
    Eur J Haematol; 1987 Mar; 38(3):231-40. PubMed ID: 3297774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplasmin activity in carrageenin-induced inflammation of rats.
    Kosugi T; Kinjo K; Takagi I; Matsuo O; Mihara H; Nishikaze O
    Int J Tissue React; 1981 Dec; 3(3-4):173-6. PubMed ID: 7333644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.
    Egbring R; Seitz R; Blanke H; Menges T; Südhoff R; Stober T; Kolb G; Lerch L
    Prog Clin Biol Res; 1989; 308():971-6. PubMed ID: 2789404
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical determination of intracellular polymorphonuclear leukocyte elastase content in patients with severe bacterial infection and septicaemia correlated with coagulation parameters.
    Eldanasouri N; Seitz R; Wolf M; Egbring R; Elden AS; Havemann K
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():575-80. PubMed ID: 2127877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin inhibitors and fibrinogen breakdown during the initial phase of thrombolytic treatment--the problem of the alpha 2-antiplasmin determination.
    Noll G; Lämmle B; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):334-7. PubMed ID: 6238441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.